Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, presents a significant global health challenge, particularly in low-resource settings. This article outlines comprehensive strategies for effective management of enteric fever, with a focus on diagnosis, treatment, and prevention.
Accurate and timely diagnosis is essential for effective management of enteric fever. Blood culture remains the gold standard for diagnosis, although its sensitivity can be low. Rapid diagnostic tests (RDTs) are increasingly used due to their ease of use, but their sensitivity and specificity vary. Molecular techniques, such as PCR, offer promise for future diagnostics but require further validation.
Antibiotic therapy is the cornerstone of enteric fever treatment. However, the emergence of multidrug-resistant strains necessitates a judicious use of antibiotics. Fluoroquinolones, the third-generation cephalosporins and azithromycin are currently recommended for treatment. It is crucial to monitor the local antimicrobial resistance patterns and adapt the treatment strategy accordingly.
Prevention strategies for enteric fever include improved sanitation, safe water supply, and vaccination. Typhoid conjugate vaccines (TCVs), providing longer-term protection and suitable for children under two, have been WHO-prequalified and are recommended for use in endemic areas. However, vaccine coverage remains suboptimal in many regions.
Strengthening healthcare systems is key to managing enteric fever effectively. This includes improving laboratory infrastructure for accurate diagnosis, training healthcare workers in case management, and establishing surveillance systems for monitoring disease burden and antimicrobial resistance.
Effective management of enteric fever requires a comprehensive approach encompassing accurate diagnosis, appropriate treatment, prevention measures, and strengthening of healthcare systems. Given the global burden of this disease, it is imperative for healthcare professionals to stay updated on the latest strategies for enteric fever management.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation